The genetic analysis of mitochondrial diseases has been complicated by the existence of dual control by nuclear and mitochondrial DNA (mtDNA) of mitochondrion formation and by the interplay of the two genomes in this process (3) . Another difficulty in the study of the diseases associated with mtDNA mutations has been the variable degree of penetrance of the defect (25, 27, 32) . This variability reflects the frequent coexistence in the same individual of mutated and nonmutated mtDNA in varying proportions, often with tissue-to-tissue differences (11-13, 23, 27, 29, 34) , as well as the influence of the nuclear background in the phenotypic manifestation of the mtDNA-encoded defect (15, 27, 32) . Also, the molecular dissection of the defect has been hindered by the pleiomorphic character of the clinical syndromes and the striking tissue specificity of the mitochondrial dysfunction (5, 8, 20, 31) .
We have recently developed novel approaches for mitochondrion-mediated transformation of human cells which can find application in the genetic and molecular analysis of mitochondrial diseases. In particular, several human cell lines completely devoid of mtDNA (p°) have been isolated by long-term exposure of the cells to low concentrations of ethidium bromide (15) . Owing to the lack of a functional respiratory chain, these cell lines have become auxotrophic for pyrimidines and pyruvate. Loss of either of these two requirements has been used as a selectable marker for the repopulation of the human p0 cell lines with exogenous mitochondria from different human sources (15) .
In the present study, the methodology described above was utilized to investigate the genetic and molecular basis of a mitochondrial protein synthesis defect found in myoblasts from a patient affected by a mitochondrial myopathy. The results clearly show (i) that the genetic defect responsible for the protein synthesis alteration could be transferred to different human mtDNA-less cell lines with the patient's mitochondria, and therefore resided in mtDNA; (ii) that the * Corresponding author.
transformants obtained with different myoblasts from the proband contained either mutated or wild-type mtDNA, pointing to mtDNA heteroplasmy in the myoblasts which was probably to great extent intercellular; and (iii) that the occurrence of the protein synthesis alteration in the transformants was correlated with a marked respiratory deficiency. Furthermore, DNA sequence analysis revealed the presence of the tRNALYS mutation, recently found in patients suffering from myoclonic epilepsy and ragged red fiber (MERRF) syndrome (27) , in the mtDNA of the transformants derived from the defective myoblasts of the proband.
MATERIALS AND METHODS
Cell lines and media. The p°206 cell line (15) , a derivative of 143B.TK-cells, was grown in Dulbecco modified Eagle medium (DMEM) with 4.5 mg of glucose per ml, supplemented with 5% fetal bovine serum (FBS), 50 ,ug of uridine per ml, and 100 ,ug of 5-bromodeoxyuridine (BrdU) per ml. The p°701.2a cell line was obtained from the simian virus 40 T-antigen gene-transformed derivative (701.2.8c [33a] ) of the human fibroblast strain GM701 (10) by long-term exposure to a low concentration of ethidium bromide (14a) . It was grown in DMEM with 10% FBS and 50 ,ug of uridine per ml. The p°13.1 cell line was obtained by long-term exposure to ethidium bromide of an adenine phosphoribosyltransferaseless mutant of 143B.TK-(isolated by two-step selection in the presence of 8-azaadenine [la] ). It was grown in DMEM with 10% FBS, 50 pug of uridine per ml, and 50 ,ug of 8-azaadenine per ml. 143B.TK-cells were grown as previously described (15) .
Myoblast cultures and isolation of myoblast clones. Mass myoblast cultures were established by a previously established procedure (16) , using muscle biopsy specimens from the proband and from four normal adult individuals. Myoblast clones were isolated as previously reported (17) by plating a mass myoblast culture at a low density (-200 myogenic colonies by the appearance of initial fusion, and trypsinizing them in a glass ring.
Mitochondrion-mediated transformation. p0 cell transformation by cytoplast fusion was done as previously described (15) . Approximately 6,000 proband myoblasts from a mixed culture of five clones were enucleated (microscopic inspection of the cytoplast preparation revealed the great efficiency of the enucleation step [>90%]) and fused to -2 x 106 p°206 cells, and transformants were isolated in DMEM supplemented with 5% dialyzed FBS and 100 ,ug of BrdU per ml. In other experiments, two such transformants were fused to p°13.1 cells as detailed in the text, using DMEM supplemented with 10% dialyzed FBS and 50 ,ug of 8-azaadenine per ml as a selective medium. In still other experiments, cytoplasts from several hundred to several thousand cells of each of five myoblast clones from the proband (1 to 5) were fused to a 200-to 2,000-fold excess of p°206 cells or p°701.2a cells, and transformants were isolated in DMEM with 5% dialyzed FBS.
Mitochondrial protein synthesis analysis. Samples of mass myoblast cultures from the proband or control individuals, of a mixed culture of five myoblast clones, or of individual transformants were labeled with [35S]methionine (1,000 Ci/ mmol, 125 to 500 uCi/ml) for 1.2 to 2 h, as detailed in the figure legends, in the presence of 100 ,ug of emetine per ml in methionine-free DMEM supplemented with 10% dialyzed FBS. 143B cells were similarly labeled for 1.2 h. After the labeling, 2 volumes of complete DMEM were added, and the cells were then washed once with DMEM and twice with buffered saline lacking Mg2' and Ca2+ (TD), trypsinized, washed twice with TD, and finally resuspended in TD containing 1 mM phenylmethylsulfonyl fluoride and lysed with 1% sodium dodecyl sulfate (SDS). In some experiments, cells were labeled in 16-mm microwells, washed, and directly lysed in 10 mM Tris (pH 7.3)-0.1 mM EDTA-1 mM phenylmethylsulfonyl fluoride containing 1% SDS. Samples of the various cell suspensions were run on SDS-exponential polyacrylamide gradient gels (7) . In some experiments, a sample of an SDS lysate of the mitochondrial fraction from 2-h [35S]methionine-labeled HeLa cells, prepared as previously described (6) Cytochrome c oxidase (COX) activity was measured in duplicate to quadruplicate on two to three samples of isolated mitochondrial fraction as previously described (28) . The mtDNA concentration of these samples was determined by dot-blot analysis as described elsewhere (15) .
Chromosome analysis. Cells were arrested in metaphase by treatment with 0.05 ,ug of colchicine per ml for 3 to 5 h or with 0.1 ,ug of vinblastine sulfate per ml for 15 to 22 h. Karyotype analysis was done as described previously (18) .
RESULTS
Protein synthesis defect in proband myoblasts. Figure 1 shows the pedigree of the family to which the proband (P) belonged (4) . In this family, two members exhibited a typical MERRF syndrome, with myoclonus and episodes of generalized tonic-clonic seizures, progressive myopathy with ragged red fibers in the muscle biopsy specimen, deafness, and cerebellar abnormalities. Other members, including the proband, exhibited mainly myopathy symptoms, ragged red fibers, lactic acidosis, and electromyogram abnormalities. Other members had no obvious clinical symptoms but some laboratory signs of disease, such as ragged red fibers, lactic acidosis, and electrocardiogram or electroencephalogram abnormalities. Finally, other members appeared normal at the clinical and laboratory examination. All affected members were related through maternal lineages. The clinical and biochemical characterization of the pedigree will be reported elsewhere (4a) .
A histochemical analysis of a muscle biopsy specimen from the proband had previously revealed the presence of ragged red fibers (about 40% of the fibers) and COX-negative and succinate dehydrogenase-positive fibers (about 30% of the fibers) (4a). Furthermore, a Southern blot analysis of the muscle DNA had failed to show the presence of any gross deletions of mtDNA. In the present work, a mass myoblast culture from the proband was tested for mitochondrial protein synthesis, in parallel with mass myoblast cultures from three normal individuals. The pattern of the mitochon- drial translation products from the proband was indistinguishable from that of the three control myoblast cultures, except for the presence of a band migrating slightly faster than ND4 (Fig. 2a, asterisk ). Figure 2a also shows the mitochondrial translation pattern from HeLa cells, which differs from that of other human cells for a previously described ND3 polymorphism (22) . That the abnormal pattern of mitochondrial protein synthesis observed in the mass myoblast culture from the proband was due to the predominant myoblasts in the culture and not to fibroblasts was shown by the experiment illustrated in Fig. 2b . In this experiment, the mitochondrial translation products of a mixture of five myoblast clones isolated from the mass myoblast culture were analyzed in an SDS-polyacrylamide gel, in parallel with the mitochondrial translation products of HeLa cells. The pattern from the proband myoblast clones again exhibited the abnormal band migrating faster than ND4, as well as two minor abnormal bands (indicated by small arrows).
Phenotype transfer with proband mitochondria. To investigate whether the abnormal pattern of mitochondrial protein synthesis observed in the proband myoblasts was due to an mtDNA or a nuclear DNA mutation, we fused enucleated cells (cytoplasts) from the proband myoblast clone mixture, in the presence of polyethylene glycol, with a large excess of the p°206 derivative of the BrdU-resistant 143B.TK-cells (15 (14a) from an adenine phosphoribosyltransferase-less mutant of 143B.TK-by long-term exposure to a low concentration of ethidium bromide, was used as a recipient. The 8-azaadenine resistance of this cell line provided a convenient selectable marker to discriminate between the mitochondrial transformants and any residual nonenucleated p0206 transformants or hybrids of these with p°13.1, since the latter were expected to be sensitive to the drug. In two fusion experiments with -1.5 x 105 pTl or pT3 cells and a 10-fold excess of p°13.1 cells, 10 or 9 transformant colonies, respectively, were isolated in selective medium represented by DMEM supplemented with 50 ,ug of 8-azaadenine per ml. In a control experiment with 3.1 x 106 cells of a p°206 transformant derived from a proband myoblast clone (no. 2, see below), no 8-azaadenine-resistant spontaneous mutants appeared during a 3-week culture in the presence of 50 ,ug of the drug per ml. This experiment strongly argued against the possibility of the putative p°13.1 transformants being instead spontaneous 8-azaadenine-resistant mutants of the p°206 transformants. Five p°13.1 transformants obtained with pTl, when tested for mitochondrial protein synthesis, revealed a defective pattern (Fig. 4) 30 Fg of protein run on gel) and panel c shows the rate Of 02 consumption and the level of COX activity (with error bars representing two standard errors) in five mitochondrial transformants (pT1 to pT5) generated from p°206 cells by fusion with cytoplasts from a mixture of five myoblast clones from the proband (Fig. 2) (Fig. 3a) . Samples of SDS lysates containing 3.4 p.g of protein were run on the gel. Transformants were tested for mitochondrial protein synthesis 6 weeks after fusion. Abbreviations are defined in the legend to Fig. 2. mitochondrial protein synthesis. Three of the clones, 2, 3, and 5, produced transformants exhibiting an altered protein synthesis pattern, while the remaining two clones generated transformants exhibiting a normal pattern (Fig. 3b) . Note that the original clone 2 myoblasts also produced an altered pattern of mitochondrial translation products. With the obvious qualifications imposed by the limited number of clones analyzed, this experiment, together with the previous one, thus suggested that about 50% of the myoblast clones were derived from myoblasts with exclusively or predominantly defective mtDNA. This may be an underestimate of the proportion of the defective myoblasts in the original muscle culture, considering the probable selective advantage for clonal growth and for transforming capacity of the myoblasts with predominantly wild-type mtDNA. Myoblast clone 2 was also used to transform another p0 human cell line, p°701.2a, genetically unrelated to 143B.TK-, which exhibited the uridine and pyruvate dependence previously shown for p0206 and p°101 (2, 15) . Several transformants were obtained from p°701.2a by fusion with cytoplasts from clone 2 and selection in medium not supplemented with uridine. In this medium, only cybrids between clone 2 myoblasts and p°701.2a cells and possibly hybrids involving any residual nonenucleated myoblasts were expected to survive. Karyotype analysis of two transformants (pT71, pT72) revealed chromosome numbers (69 to 108, 85 to 109) higher than the range of values observed in p0701.2a cells (60 to 68), although in general lower than the number of chromosomes expected for hybrids (-110). In view of the high frequency of enucleation (>90%) and of the usually much greater efficiency of cybrid versus hybrid formation, it is likely that the isolated transformants represented cybrids with an increased parental (701.2.8c) chromosome number. The pT71 and pT72 transformants were analyzed for mitochondrial protein synthesis, and they exhibited the same alterations of the mitochondrial translation products observed in the defective proband myoblasts and the p°206 transformants derived from them (Fig. 3b) .
One unaffected member of the family of the proband, related to him by a paternal lineage (R in Fig. 1) , was subjected to the same analysis as the proband. A myoblast culture derived from a biopsy specimen from this individual, as well as seven transformants obtained from p°206 cells by cytoplast fusion with these myoblasts, when tested for mitochondrial protein synthesis, revealed a normal pattern of mitochondrial translation products (data not shown).
Respiration defect in transformants. It seemed likely that the alteration in the protein synthesis pattern observed in the proband myoblasts and in some of the p0 transformants derived from them was related to the disease phenotype of the proband. Strong support for this idea was provided by the analysis of the respiratory properties of the transformants. In fact, of the five transformants obtained with p°206 as the recipient, the two which exhibited an altered protein synthesis pattern (pT1 and pT4) showed a marked decrease in 02 consumption compared with the transformant derived from the normal individual (C4) and with the parental 143B cells (Fig. 3c) . By contrast, the three transformants which exhibited a normal protein synthesis pattern (pT2, pT3, and pT5) also showed a normal 02 consumption. Similarly, the four transformants produced with clone 2 from p°206 (pT21, pT22) or from p°701.2a (pT71, pT72), which showed a protein synthesis defect, all exhibited a strong decrease in 02 consumption (Fig. 3d) . Therefore, there appeared to be a perfect correspondence between altered protein synthesis pattern and respiratory deficiency in all transformants analyzed.
Two of the p0206 transformants obtained by cytoplast fusion using myoblasts from the unaffected member of the family (R), which were mentioned above, when tested for 02 consumption, exhibited rates very similar to that of 143B (data not shown).
A reasonable interpretation of the respiratory deficiency observed in the defective transformants was that it was due to the marked decrease, as a result of the severe protein synthesis defect, in the rate of assembly of functional respiratory complexes which are under dual (mitochondrial and nuclear) genetic control. This interpretation was supported by the results of measurements of activity of one such complex, COX, in the transformants. All transformants exhibiting a strong reduction in the rate of 02 consumption also showed a pronounced decrease in COX activity per milligram of mitochondrial protein, relative to the parental 143B cells (Fig. 3c and d) . Similarly, all transformants with normal 02 consumption exhibited a normal COX activity. Normalization of the COX data for the mtDNA content of the mitochondrial fraction, determined by dot-blot analysis as previously described (15) the assembly of these subunits in pTl was found not to be an on a gel in parallel affected when compared to the assembly in pT3 or 143B thionine-labeled 143B (data not shown). The above observations tended to exclude I to Fig. 2. a ribosomal involvement in the pTl defect and pointed to a tRNA gene as the probable site of the mutation.
A Southern blot analysis of total cell DNA from pTl, pT3, rived therefrom reand 143B, digested with XbaI and probed with HeLa cell al bands. This sugmtDNA 32p labeled by random priming, revealed all the involve any single expected fragments in the same relative amounts in the three ether the abnormal samples (Fig. 6a) digests (data not shown). In another Southern blot experiment involving MboI, both pT1 and pT3 mtDNA revealed a fragment length polymorphism which distinguished the transformant mtDNA from that of 143B.TK-, the parental line of p°206 (Fig. 6b) . It is also clear from the blots in Fig.  6 that the pTl and pT3 transformants contain approximately equivalent amounts of mtDNA; these amounts are also similar to the amount of mtDNA in 143B cells, previously determined to be -9,100 molecules per cell (15) .
Very recently, a report (27) has appeared linking the occurrence of an mtDNA tRNALYS A-to-G transition at position 8344 (1) to the MERRF syndrome. Since two members of the proband family investigated in the present work exhibited a full MERRF syndrome, and since the proband myoblasts and the transformant cultures derived therefrom showed a protein synthesis defect, it seemed possible that the mtDNA mutation causing this defect was a tRNALYS mutation at position 8344. Indeed, sequence analysis of the polymerase chain reaction-amplified mtDNA fragment encompassing the tRNALYS gene from pT1, pT3, and 143B cells revealed the A-to-G transition in pTl and its absence in pT3 and 143B (Fig. 6c) . Although a precise quantitation could not be done, it appeared that all or at least the great majority of pTl mtDNA was mutated and that all or the great majority of pT3 mtDNA was wild type at position 8344. Further tests showed that the mtDNA of all transformants thus investigated which exhibited protein synthesis and respiratory defects contained exclusively or in great predominance G at position 8344, whereas the mtDNA of all transformants analyzed which were phenotypically normal contained A at the same position (Fig. 7) . Figure 7 summarizes the genetic and phenotypic characteristics of the cellular pedigree constructed in the present work with the proband myoblast clones and three different p0 human cell lines. In this diagram, the purely or predominantly defective genotype and phenotype of the original individual myoblast clones was inferred from that of the transformants derived therefrom. For this inference, the plausible assumption was made, in agreement with previous evidence (15, 30) , that there was no intracellular and/or intercellular selective advantage of mutated, nonfunctional mtDNA over wild-type mtDNA during in vitro growth. The correctness of this assumption was directly verified, at least as concerns the phenotype, for one of the clones (no. 2). On the contrary, the assignment of a wild-type genotype and phenotype to some of the original myoblast clones did not exclude the presence in these of a portion of mutated mtDNA which could have been lost by selection during in vitro growth.
DISCUSSION
Several conclusions can be drawn from the data of Fig. 7 . (i) The perfect correlation observed in the transformants between the presence or absence of a protein synthesis defect, an 02 consumption defect, and COX deficiency, on the one hand, and the presence or absence of the mitochondrial tRNALYS gene mutation, on the other hand, shows that the mtDNA carrying this mutation was at least in part responsible for the defective phenotype, thus establishing a direct link between mtDNA alteration and biochemical defect. Considering the evidence recently reported concerning the causal role of the tRNALYS mutation in the pathogenesis of MERRF (27) , it is reasonable to assume a similar role in the proband's disease. However, one cannot exclude a possible exacerbating role of another mtDNA mutation(s) coexisting with the tRNALYS mutation in the genesis of the disease investigated here.
(ii) The observation that the defective mtDNA produced the disease phenotype in the original nuclear background of the proband and in one genetically unrelated nuclear background, that of p°206 (or two, if the 701.2a transformants are indeed cybrids), strongly suggests that the mtDNA carrying the tRNALYs mutation was also sufficient by itself to produce the disease in the proband, without the involvement of a deleterious nuclear gene(s).
(iii) The presence of either mutated or nonmutated mtDNA was observed in the transformants derived from the 10 proband myoblast clones investigated here. mtDNA heteroplasmy has been previously reported in tissues or blood in other cases of mitochondrial disease (11-13, 23, 27, 29, 34) . In an analysis of clonal cultures from patients with Kearns-Sayre syndrome, individual muscle or fibroblast clones were found to contain either only normal mtDNA or a heteroplasmic population of normal and deleted mtDNA, with occasional clones containing a high proportion (60 to 70%) of deleted mtDNA (19) . In the present work, heteroplasmy in the myoblasts was probably to a large extent intercellular. The data obtained, in fact, suggest that at least 50% of the myoblasts in the original myoblast culture contained exclusively or in great predominance defective mtDNA. This figure agrees roughly with the percentages of ragged red fibers and COX-negative fibers determined in the histochemical analysis of the muscle biopsy specimen. The possibility of analyzing both defective and normal myoblasts from the same individual has provided a powerful tool in the present work to correlate the defective genotype with the defective phenotype. Since the selection scheme used for the isolation of transformants depended on the presence of functional mitochondria in the cytoplasts, one must conclude that either the mutated mtDNA molecules allowed a minimal level of respiratory function in the defective myoblasts or that these myoblasts contained a small amount of wild-type mtDNA not detectable in the DNA sequence analysis performed here.
It seems very likely that the tRNALYS mutation caused the disease phenotype in the proband by severely inhibiting mitochondrial protein synthesis in the myoblasts, and probably in other cells, and thus by drastically affecting the assembly of respiratory complexes. In favor of this mechanism of action of the tRNALYs mutation is the observation that, although the synthesis of all polypeptides in the defective transformants was severely affected, there was a tendency for this inhibition to be more complete the higher the number of lysine residues in the polypeptides (data not shown). The abnormal translation products observed in the defective myoblasts and transformants derived therefrom most probably represent incomplete polypeptides resulting from premature termination. Consistent with this interpretation is the finding that the abnormal polypeptide migrating faster than ND1 (Fig. 2b and 3 ) was precipitable by antibodies directed against the NH2-terminal octapeptide of ND2 (data not shown). The observed inhibition of activity of the respiratory chain enzyme COX is most probably a consequence of the reduced rate of assembly of the COX complex, owing to the drastically curtailed synthesis of the mtDNAencoded subunits I, II, and III, and is therefore consistent with the interpretation discussed above of the mechanism of action of the tRNALYS mutation.
The tRNALYs mutation affects a conserved nucleotide in the TVC loop (27) . This loop is known to reside, with the D loop, at the corner of the L-shaped tridimensional structure of the tRNAs (14) and to be involved in the interaction of the tRNA with the ribosomal surface (24). Therefore, it seems possible that the mutation at position 8344 affects protein synthesis by interfering with the binding of the charged tRNALYs to the ribosome. On the other hand, in view of what is known about the specific interaction of the aminoacyl-tRNA synthetases with the tRNA molecules (21), one cannot exclude that the mutation affects the charging of the tRNALYS. A third possibility is that the mutation interferes with the processing of the tRNALYS and thereby affects its stability. In any case, it is clear that the availability of established transmitochondrial cell lines carrying the tRNALYS mutation makes the mechanism of this mutation accessible to investigation.
The development of cellular models of mitochondrial diseases, like that described in the present work, will open the way to the analysis of the genetic origin of the defect in other diseases, to the investigation of the role of mtDNA heteroplasmy and of the nuclear background in the penetrance of the disease, to the molecular dissection of the defect, and, in the future, to the establishment of rational therapeutic approaches for the treatment of the disease.
